Effects of cilostazol, a phosphodiesterase inhibitor, on urinary excretion of albumin and prostaglandins in non-insulin-dependent diabetic patients.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Diabetes Research and Clinical Practice

• Publication date

  1993-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0168-8227(93)90132-OPMID 8137717
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Contribution of platelet thromboxane production to enhanced urinary excretion and glomerular production of thromboxane and to the pathogenesis of albuminuria in the streptozotocin-diabetic rat.

  1992cited by this paper
• The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus

  1991cited by this paper
• Reduction of urinary albumin excretion by thromboxane synthetase inhibitor, OKY-046, through modulating renal prostaglandins in patients with diabetic nephropathy.

  1990cited by this paper
• Effects of captopril on urinary excretion of albumin and prostaglandins in patients with diabetic nephropathy.

  1990cited by this paper
• Renal function in black Americans with type II diabetes.

  1989cited by this paper
• Renal effects of prostaglandin E1 in type 2 (non-insulin-dependent) diabetic patients with subclinical nephropathy.

  1989cited by this paper
• Role for local prostaglandin and thromboxane production in the regulation of glomerular filtration rate in the rat with streptozocin-induced diabetes.

  1989cited by this paper
• Enhancement of Platelet Aggregation by Low-Density Lipoproteins From IDDM Patients

  1988cited by this paper
• Elevated Urinary Prostaglandin Excretion and the Effect of Indomethacin on Renal Function in Incipient Diabetic Nephropathy

  1988cited by this paper
• Effects of thromboxane A2 synthesis inhibition on renal renin release and protein excretion in diabetic rats.

  1988cited by this paper
• Contrasting effects of captopril and nifedipine in normotensive patients with incipient diabetic nephropathy.

  1988cited by this paper
• Renal Hemodynamics and Urinary Excretion of 6-Keto-Prostaglandin F1α and Thromboxane B2 in Newly Diagnosed Type I Diabetic Patients

  1988cited by this paper
• Acute and Long‐term Renal Effects of Angiotensin Converting Enzyme Inhibition in Normotensive, Normoalbuminuric Insulin‐dependent Diabetic Patients

  1988cited by this paper
• Effects of indomethacin on kidney function in Type 1 (insulin-dependent) diabetic patients with nephropathy

  1987cited by this paper
• Increased thromboxane B2 excretion in diabetes mellitus.

  1987cited by this paper
• Sequential alterations in glomerular prostaglandin and thromboxane synthesis in diabetic rats: relationship to the hyperfiltration of early diabetes.

  1987cited by this paper
• Urinary excretion and renal production of prostaglandins E2, F2 alpha, and thromboxane B2 in experimental diabetes mellitus.

  1986cited by this paper
• Evaluation of a New Radioimmunoassay for Urinary Albumin

  1986cited by this paper
• Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes.

  1986cited by this paper
• Acute and long-term effect of antihypertensive treatment on exercise-induced albuminuria in incipient diabetic nephropathy.

  1986cited by this paper
• Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins.

  1985cited by this paper
• Clinical effects of oral cilostazol on suppression of platelet function in patients with cerebrovascular disease.

  1985cited by this paper
• Effect of cilostazol on platelet aggregation and experimental thrombosis.

  1985cited by this paper
• Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus.

  1985cited by this paper
• The Stages in Diabetic Renal Disease: With Emphasis on the Stage of Incipient Diabetic Nephropathy

  1983cited by this paper
• Changes in blood pressure, urinary kallikrein, and urinary prostaglandin E2 in rats with streptozotocin-induced diabetes

  1983cited by this paper
• Kidney function and size in type 1 (insulin-dependent) diabetic patients before and during growth hormone administration for one week

  1982cited by this paper
• Production of 6-oxo-prostaglandin F1 alpha and prostaglandin E2 by isolated glomeruli from normal and diabetic rats.

  1982cited by this paper
• Effect of intravenous glucose infusion on renal function in normal man and in insulin-dependent diabetics

  1981cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• The effect of short-term glucagon infusion on kidney function in normal man

  1977cited by this paper
• Plasma Renin Activity and Hypertension in Diabetes Mellitus

  1976cited by this paper
• Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma.

  1973cited by this paper
• Plasma catecholamines in long-term diabetics with and without neuropathy and in hypophysectomized subjects.

  1972cited by this paper

• The Role of Platelets in Diabetic Kidney Disease

  2022cites this paper
• Effect of Cilostazol as an Antiplatelet Agent on Diabetic Nephropathy with Macroalbuminuria: A Randomized, Double-Blind, Placebo-Controlled Trial (ATP-DN)

  2022cites this paper
• Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial

  2014cites this paper
• Diabetic nephropathy – complications and treatment

  2014cites this paper
• The Vascular and Biochemical Effects of Cilostazol in Diabetic Patients With Peripheral Arterial Disease

  2009cites this paper
• Treating peripheral arterial disease in patients with diabetes

  2002cites this paper
• Urinary thromboxane A2/prostacyclin balance reflects the pathological state of a diabetic.

  1999cites this paper
• The adipocyte cGMP-inhibited cyclic nucleotide phosphodiesterase (PDE3B) as a target for lipolytic and thermogenic agents for the treatment of obesity

  1999cites this paper
• Elevation of the Thromboxane A2/Prostacyclin Ratio in Urine of Diabetic Mice Analyzed by Gas Chromatography/Selected Ion Monitoring

  1998cites this paper
• Prostaglandins and diabetic nephropathy.

  1995cites this paper